Search - tctmd.com

Displaying 21 - 40 of 46

Sort: Relevancy | Date

Presentation TCT 2018

Constrictive Pericarditis or Restrictive Cardiomyopathy Hemodynamic Old School

Presenter: Morton J. Kern, Holger Thiele, Gerhard C. Schuler

September 23, 2018

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

Presentation TCT 2018

Hypertrophic Cardiomyopathy - Brockenbrough Phenomenon and More

Presenter: Morton J. Kern, Holger Thiele, Joseph P. Carrozza Jr

September 23, 2018

News Conference News ESC 2018

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

Shelley Wood

September 14, 2018

News Conference News ESC 2018

Tafamidis, a Transthyretin Stabilizer, Offers Hope for Rare Cardiomyopathy

Michael O'Riordan

August 27, 2018

News Conference News ESC 2018

MITRA-FR: No Benefit of MitraClip in Functional MR

Shelley Wood

August 27, 2018

News Daily News

AHA Scientific Statement Aims to Raise Awareness of Chagas Disease and Risk for Cardiomyopathy

Lucy Hicks

August 24, 2018

News Daily News

‘Classic’ Takotsubo? Not So Fast: Different Presentations Could Spell Diverse Prognoses

Yael L. Maxwell

August 16, 2018

News Daily News

Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes

Michael O'Riordan

August 09, 2018

News Conference News The Structural Heart Disease Summit 2018

Hybrid Surgical/Interventional LV Reconstruction Improves Ejection Fraction and Patient Symptoms

Michael O'Riordan

June 27, 2018

News Conference News EuroPCR 2018

Pace Quickens for Mitral Device Innovation for Repair, Replacement

Yael L. Maxwell

May 24, 2018

News Features

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

Caitlin E. Cox

May 02, 2018

Presentation ECHO 2018

When Contrast Saves the Day and other Diagnostic Conundrums

Presenter: Leo Marcoff

April 19, 2018

Presentation ECHO 2018

Infiltrative and Restrictive Cardiomyopathy: Recognition by Echo

Presenter: Gerard P. Aurigemma

April 19, 2018

Presentation ECHO 2018

Hypertrophic Cardiomyopathy

Presenter: Muhamed Sarić

April 19, 2018

News Industry News

Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center Hamburg

April 05, 2018

News Daily News

Drug for Rare Form of Cardiomyopathy Meets Primary Endpoint in Phase III Trial

Todd Neale

March 30, 2018

News Daily News

ESC Releases New Syncope Guidelines

Shelley Wood

March 20, 2018

News Daily News

Genetic Testing for Cardiomyopathy Less Useful for Racial Minorities

Todd Neale

March 06, 2018

News Conference News CRT 2018

Is COAPT Designed to Fail? Experts Debate Treatment Timing in Severe Functional MR

Michael O'Riordan

March 05, 2018

Advertisement

Constrictive Pericarditis or Restrictive Cardiomyopathy Hemodynamic Old School

High Mortality but Durable Results With Valve-in-Valve TAVR

Hypertrophic Cardiomyopathy - Brockenbrough Phenomenon and More

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

Tafamidis, a Transthyretin Stabilizer, Offers Hope for Rare Cardiomyopathy

MITRA-FR: No Benefit of MitraClip in Functional MR

AHA Scientific Statement Aims to Raise Awareness of Chagas Disease and Risk for Cardiomyopathy

‘Classic’ Takotsubo? Not So Fast: Different Presentations Could Spell Diverse Prognoses

Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes

Hybrid Surgical/Interventional LV Reconstruction Improves Ejection Fraction and Patient Symptoms

Pace Quickens for Mitral Device Innovation for Repair, Replacement

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

When Contrast Saves the Day and other Diagnostic Conundrums

Infiltrative and Restrictive Cardiomyopathy: Recognition by Echo

Hypertrophic Cardiomyopathy

Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center Hamburg

Drug for Rare Form of Cardiomyopathy Meets Primary Endpoint in Phase III Trial

ESC Releases New Syncope Guidelines

Genetic Testing for Cardiomyopathy Less Useful for Racial Minorities

Is COAPT Designed to Fail? Experts Debate Treatment Timing in Severe Functional MR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content